NFKB1 and cardiac hypertrophy: Using EMSA, we demonstrated in the current study that ATF3 overexpression increased DNA binding activity of NF-κB and Nkx-2.5, while the binding activity of AP-1, transcription factor mainly related to pathological cardiac hypertrophy [7], [50], remained unchanged.